LABCORP HOLDINGS INC
LHNYSETrading Snapshot
- Day Range
- $307.02 – $313.15
- 52-Week Range
- $244.52 – $341.80
- Volume
- $2.69B
- Avg Volume
- $2.55B
- Shares Outstanding
- 82.0M
- Next Earnings
- Nov 30, 2026
Fundamentals Snapshot
- Annual Revenue
- $13.95B
- Last Q Revenue
- $3.73B
- P/E Ratio
- 25.4
- P/S Ratio
- 1.8x
- EPS (TTM)
- $12.27
- Dividend Yield
- 0.93%
- Dilution (1yr)
- −1.2%
Why Investors Own LH
- ✓High-growth profile — revenue up +53.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 57% gross margin and 17% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
LABCORP HOLDINGS INC
LH
StockOtter · stockotter.spaceAbout LABCORP HOLDINGS INC
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
LH expands specialty testing and consumer services through acquisitions, partnerships and AI, while reimbursement and cost risks remain.
Labcorp (NYSE:LH) Shares Gap Down – Should You Sell?
Labcorp Holdings Inc. (NYSE: LH - Get Free Report) shares gapped down prior to trading on Tuesday. The stock had previously closed at $320.99, but opened at $303.46. Labcorp shares last traded at $313.95, with a volume o
Critical Survey: HCA Healthcare (NYSE:HCA) and Labcorp (NYSE:LH)
HCA Healthcare (NYSE: HCA - Get Free Report) and Labcorp (NYSE: LH - Get Free Report) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of
Labcorp: The CMS Selloff Represents An Excellent Opportunity - Strong Buy
Labcorp shares dropped sharply after CMS released preliminary 2027 lab-payment rates, aligning Medicare rates closer to private insurers and targeting $1B annual savings. I see the selloff as overdone, with market fears
Labcorp's Future Driven By Clinical Testing Demand, Despite Impact From Medicare Cuts
Labcorp Holdings Inc. is upgraded to Buy, supported by resilient demand for diagnostics and robust Q2 results, despite upcoming Medicare rate cuts. LH outperformed both the S&P 500 and healthcare peers YTD, with strong t
Why Labcorp Holdings Stock Dropped Today
Medicare and Medicaid have been overpaying Labcorp for years, says the government. Starting next year, they plan to cut reimbursement of lab testing by 15%.